Onderneming Momenta Pharmaceuticals, Inc.
Aandelen
MNTA
US60877T1007
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Lee
PSD | President | - | - |
Patty Eisenhaur
IRC | Investor Relations Contact | - | - |
Comptroller/Controller/Auditor | - | 01-04-19 | |
Ian D. Fier
PRN | Corporate Officer/Principal | - | 01-10-02 |
Human Resources Officer | - | 01-10-07 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | 01-10-20 | |
Director/Board Member | - | 01-10-20 | |
Jonathan Bryant
BRD | Director/Board Member | - | 01-10-20 |
David Lee
PSD | President | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 119 533 224 | 118 124 353 ( 98,82 %) | 568 000 ( 0,4752 %) | 98,82 % |
Bedrijfsgegevens
Momenta Pharmaceuticals, Inc.
1125 Trenton-harbourton Road
08560, Titusville
+617 491 9700
http://www.momentapharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,42% | 104 mld. | |
+4,29% | 97,47 mld. | |
+5,68% | 22,25 mld. | |
-13,59% | 21,68 mld. | |
-9,70% | 18,2 mld. | |
-39,98% | 17,02 mld. | |
-11,72% | 16,36 mld. | |
+8,46% | 14,39 mld. | |
+41,01% | 12,37 mld. |